Novel Biomarkers for the Diagnosis, Prognosis and Management of Acute Kidney Injury—Part II

Dear Colleagues,

In January 2021, we launched a Special Issue on the topic of “Novel Biomarkers for the Diagnosis, Prognosis, and Management of Acute Kidney Injury—Part I” (https://www.mdpi.com/journal/jcm/special_issues/Biomarkers_Kidney). In this issue, a large number of papers were published on the utilization of biomarkers in clinical practice and various patient populations, including chronic kidney disease, acute coronary syndromes, cardiac arrhythmias, and tubular damage related to various medications. These studies highlighted the central role of biomarkers of renal damage in the early identification of injury, stratification according to injury severity, etiologic specificity for injury, and prognostic information.

Given the enormous success of Part I, I believe that it is time to move forward with Special Issue Part II, collecting additional insights into the importance of renal biomarkers, handling specific prevention and treatment. With Part II, we are very keen to attract a global audience, welcoming clinical and experimental scientific reports that improve our understanding of novel biomarkers of early renal damage and their possible utilization in clinical practice.

I look forward to your valued submissions that will contribute to this important goal.

Prof. Dr. Yacov Shacham
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.